908 Devices (MASS) Gains from Investment Securities (2020)
908 Devices' (MASS) quarterly Gains from Investment Securities came in at $6.1 million in Q4 2020, up 3052.58% on a QoQ basis from $194000.0 in Q3 2020.
908 Devices (MASS) Gains from Investment Securities (2020) Analysis & Trends
908 Devices (MASS) has 1 years of Gains from Investment Securities data on file, last reported at $6.1 million in Q4 2020.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to $6.1 million in Q4 2020; TTM through Dec 2020 was $6.1 million, a N/A change from a year earlier, with the FY2020 full-year figure at $6.1 million, changed N/A from the prior year.
- Gains from Investment Securities for Q4 2020 stood at $6.1 million, up from $194000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for MASS reached as high as $6.1 million in Q4 2020 and fell as low as -$191000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn |
| 10 | 908 Devices | 261.60 Mn | 149.85 Mn | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 6.12 Mn |
| Dec 31, 2020 | 6.12 Mn |
| Sep 30, 2020 | 194,000.00 |
| Sep 30, 2020 | 194,000.00 |
| Jun 30, 2020 | -191,000.00 |
| Jun 30, 2020 | -191,000.00 |
| Mar 31, 2020 | 23,000.00 |
| Mar 31, 2020 | 23,000.00 |